Trials / Completed
CompletedNCT02551315
Microarchitecture, Bone Strength and Fracture Risk in Type 2 Diabetes
Microarchitecture, Bone Strength and Fracture Risk in Type 2 Diabetes: the DiabOS Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 274 (actual)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- All
- Age
- 50 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
This multicenter, prospective, observational cohort study will assess bone differences in women and men with type 2 diabetes mellitus (T2DM) with and without fragility fractures.
Detailed description
Cross-sectional evaluation of clinical, biochemical and microstructural measures of bone in patients with type 2 diabetes and age-matched healthy controls. Longitudinal assessment of clinical, biochemical and microstructural measures of bone in study participants without prevalent fragility fractures.
Conditions
Timeline
- Start date
- 2016-06-01
- Primary completion
- 2020-01-10
- Completion
- 2020-01-10
- First posted
- 2015-09-16
- Last updated
- 2022-12-22
Locations
5 sites across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02551315. Inclusion in this directory is not an endorsement.